137 related articles for article (PubMed ID: 35843088)
1. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J
Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L
J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling.
Li G; Wang M; Ren L; Li H; Liu Q; Ouyang Y; He L; Li F
Biomed Pharmacother; 2019 Sep; 117():109112. PubMed ID: 31212130
[TBL] [Abstract][Full Text] [Related]
4. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
5. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis.
Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY
Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414
[TBL] [Abstract][Full Text] [Related]
6. NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression.
Sun H; Zhang H; Yan Y; Li Y; Che G; Zhou C; Nicot C; Ma H
Mol Cancer; 2022 Feb; 21(1):55. PubMed ID: 35180865
[TBL] [Abstract][Full Text] [Related]
7. Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.
Inoue S; Ide H; Mizushima T; Jiang G; Netto GJ; Gotoh M; Miyamoto H
Mol Cancer Ther; 2018 Jun; 17(6):1303-1314. PubMed ID: 29592878
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt/β-catenin signaling pathway.
Zhang X; Zhu M; Wang H; Song Z; Zhan D; Cao W; Han Y; Jia J
Gene; 2021 Jan; 766():145163. PubMed ID: 32980450
[TBL] [Abstract][Full Text] [Related]
9. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
Zhang Q; Su R; Shan C; Gao C; Wu P
Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
[TBL] [Abstract][Full Text] [Related]
10. ZSCAN16 promotes proliferation, migration and invasion of bladder cancer via regulating NF-kB, AKT, mTOR, P38 and other genes.
Li X; Shang D; Shen H; Song J; Hao G; Tian Y
Biomed Pharmacother; 2020 Jun; 126():110066. PubMed ID: 32172065
[TBL] [Abstract][Full Text] [Related]
11. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression.
Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z
Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of NCAPG expression inactivates the Wnt/β-catenin signal to suppresses endometrial cancer cell growth in vitro.
Liu C; Yan Y; Di F; Li W; Yin X; Dong L
Environ Toxicol; 2021 Dec; 36(12):2512-2520. PubMed ID: 34480403
[TBL] [Abstract][Full Text] [Related]
13. NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo.
Cui X; Shen D; Kong C; Zhang Z; Zeng Y; Lin X; Liu X
Sci Rep; 2017 Jan; 7():40723. PubMed ID: 28139689
[TBL] [Abstract][Full Text] [Related]
14. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
[TBL] [Abstract][Full Text] [Related]
15. NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3β/β-catenin signaling.
Li J; Sun S; Li J; Zhao X; Li Z; Sha T; Cui Z
Neoplasma; 2021 Nov; 68(6):1201-1211. PubMed ID: 34585587
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma.
Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y
Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214
[TBL] [Abstract][Full Text] [Related]
17. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.
Zheng T; Qian T; Zhou H; Cheng Z; Liu G; Huang C; Dou R; Liu F; You X
Aging (Albany NY); 2023 Jun; 15(12):5535-5549. PubMed ID: 37335105
[TBL] [Abstract][Full Text] [Related]
18. SETD6 regulates NF-κB signaling in urothelial cell survival: Implications for bladder cancer.
Mukherjee N; Cardenas E; Bedolla R; Ghosh R
Oncotarget; 2017 Feb; 8(9):15114-15125. PubMed ID: 28122346
[TBL] [Abstract][Full Text] [Related]
19. Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation
Yuan CW; Sun XL; Qiao LC; Xu HX; Zhu P; Chen HJ; Yang BL
World J Gastroenterol; 2019 Dec; 25(47):6813-6822. PubMed ID: 31885422
[TBL] [Abstract][Full Text] [Related]
20. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
